Mission Kowa’s R&D activities are carried out at the company’s laboratories in Tokyo and Fuji. The focus is on lifestyle-related diseases, immune disorders and allergy, and dermatology and ophthalmology.
Kowa Research Institute is responsible for the U.S. development of Kowa’s new drug candidates. For an overview of Kowa’s drug candidates currently in Phase I or later clinical development please click on the following link:
Description Kowa Research Institute, Inc. located in the RTP area of North Carolina is responsible for the clinical development of Kowa Company’s new drugs in the United States. Kowa Research Institute, Inc. is a division of Kowa Co., Ltd. headquartered in Nagoya, Japan. Kowa Research Institute was established in 1997 in California and began operations at the current location in 2003.